PHARMA: ALLERGAN, IMPRIMIS TRADE ACCUSATIONS IN DISPUTE
Compounding Practice At Center of Lawsuit
Originally published September 21, 2017 at 3:26 p.m., updated September 21, 2017 at 3:26 p.m.
San Diego — A Goliath in the biotech industry is suing San Diego drugmaker Imprimis Pharmaceuticals, alleging the company is selling new drugs without regulatory approval...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know